Profile data is unavailable for this security.
About the company
Jianmin Pharmaceutical Group Co Ltd, formerly Wuhan Jianmin Pharmaceutical Groups Co Ltd, is a China-based company principally engaged in the research and development, manufacturing, wholesale and retail of pharmaceuticals. The Company operates its businesses through two segments. The Pharmaceutical Production and Sales segment is primarily engaged in the production of various types of Chinese patent medicines and sales to pharmaceutical distributors at all levels, including sales to the commercial division within the group that sells to non-hospitals. The Commercial segment is primarily engaged in the purchase of drugs from manufacturers and manufacturers' agents, and then distribution to lower-level distributors, sales to hospitals and retail sales in pharmacies. The Company mainly operates its businesses in the domestic market.
- Revenue in CNY (TTM)3.18bn
- Net income in CNY326.30m
- Incorporated1993
- Employees2.35k
- LocationJianmin Pharmaceutical Group Co LtdNo.484 Yingwu Avenue, Hanyang DistrictWUHAN 430052ChinaCHN
- Phone+86 2 784523350
- Fax+86 2 784523350
- Websitehttp://www.whjm.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZhuZhou QianJin Pharmaceutical Co., Ltd | 3.63bn | 250.04m | 5.24bn | 5.27k | 17.40 | 1.78 | -- | 1.44 | 0.6115 | 0.6115 | 8.87 | 5.98 | 0.7768 | 4.12 | 9.84 | 689,467.60 | 7.43 | 8.36 | 13.56 | 15.33 | 48.13 | 44.74 | 9.56 | 9.71 | 1.13 | -- | 0.0182 | 67.36 | -4.44 | 0.5863 | -27.98 | -4.75 | 3.10 | -6.36 |
| Shanghai New World Co Ltd | 1.10bn | 69.08m | 5.29bn | 1.14k | 76.69 | 1.25 | -- | 4.79 | 0.1067 | 0.1067 | 1.71 | 6.57 | 0.1962 | 3.93 | 11.76 | 968,234.30 | 1.22 | 0.6394 | 1.61 | 0.8838 | 40.39 | 36.38 | 6.20 | 3.58 | 1.56 | -- | 0.1118 | 71.59 | -1.21 | -7.49 | 121.22 | 13.84 | -26.50 | 5.92 |
| Jianmin Pharmaceutical Group Co Ltd | 3.18bn | 326.30m | 5.34bn | 2.35k | 16.12 | 2.07 | -- | 1.68 | 2.16 | 2.16 | 21.01 | 16.83 | 0.7435 | 3.94 | 3.46 | 1,354,202.00 | 7.77 | 10.96 | 12.83 | 19.58 | 60.52 | 44.41 | 10.45 | 10.23 | 1.40 | -- | 0.0438 | 37.54 | -16.81 | 9.38 | -30.54 | 31.68 | 11.66 | 35.10 |
| Hunan Fangsheng Pharmaceutical Co Ltd | 1.68bn | 295.36m | 5.38bn | 1.81k | 18.27 | 3.22 | -- | 3.20 | 0.6709 | 0.6709 | 3.83 | 3.81 | 0.5327 | 1.42 | 6.00 | 931,293.10 | 9.11 | 6.11 | 16.09 | 10.86 | 68.68 | 67.05 | 17.10 | 10.32 | 0.5475 | 19.04 | 0.2332 | 49.73 | 9.15 | 10.20 | 36.61 | 26.46 | -13.82 | 38.88 |
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.91m | 1.91% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2025 | 2.37m | 1.56% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 1.80m | 1.18% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 1.73m | 1.13% |
| Galaxy Asset Management Co., Ltd.as of 30 Jun 2025 | 1.17m | 0.77% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 738.86k | 0.49% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 569.76k | 0.37% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 556.01k | 0.37% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 266.40k | 0.18% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 233.60k | 0.15% |
